Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 7NIH 3INDUSTRY 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1CNS 1

Conditions

Neoplasms 1Neoplasm Metastasis 1Multiple Acyl Coenzyme A Dehydrogenase Deficiency 1Melanoma 1Lymphoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × NIH × Ganciclovir × Clear all
NCT00001328 2017-07-02

Gene Therapy for the Treatment of Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis, Neoplasms, Multiple Acyl Coenzyme A Dehydrogenase Deficiency

NCT00005057 2015-04-29

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1 Completed
Dermatologic

Melanoma

NCT00217503 2013-06-20

Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
15 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡